https://www.taxtmi.com/caselaws?id=762785 CESTAT Chennai dismissed the appeal regarding classification of imported insulin products. The dispute centered on whether biosynthetic human insulin qualified as mono-component insulin under chapter heading 3004 31 10 for exemption under Notification No. 12/2012 Customs. The tribunal held that mono-component refers to purity rather than source, and insulin manufactured using r-DNA technology qualifies as mono-component insulin despite containing protamine as a second component. The appellant was entitled to customs exemption as the classification is content-based, not source-based, distinguishing it from porcine and bovine insulin classifications. en-us Fri, 22 Nov 2024 00:00:00 +0530 Sat, 07 Dec 2024 08:14:52 +0530 TaxTMI RSS Generator https://www.taxtmi.com/caselaws?id=762785 CESTAT Chennai dismissed the appeal regarding classification of imported insulin products. The dispute centered on whether biosynthetic human insulin qualified as mono-component insulin under chapter heading 3004 31 10 for exemption under Notification No. 12/2012 Customs. The tribunal held that mono-component refers to purity rather than source, and insulin manufactured using r-DNA technology qualifies as mono-component insulin despite containing protamine as a second component. The appellant was entitled to customs exemption as the classification is content-based, not source-based, distinguishing it from porcine and bovine insulin classifications. Case-Laws Customs Fri, 22 Nov 2024 00:00:00 +0530 https://www.taxtmi.com/caselaws?id=762785